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Abstract
Background: The identification and characterization of cancer stem cells (CSCs) is imperative to understanding the
mechanism of cancer pathogenesis. Growing evidence suggests that CSCs play critical roles in the development and
progression of cancer. However, controversy exists as to whether CSCs arise from bone marrow-derived cells (BMDCs).
Methodology and Principal Findings: In the present study, n-nitrosodiethylamine (DEN) was used to induce tumor
formation in female mice that received bone marrow from male mice. Tumor formation was induced in 20/26 mice,
including 12 liver tumors, 6 lung tumors, 1 bladder tumor and 1 nasopharyngeal tumor. Through comparison of
fluorescence in situ hybridization (FISH) results in corresponding areas from serial tumor sections stained with H&E, we
determined that BMDCs were recruited to both tumor tissue and normal surrounding tissue at a very low frequency (0.2–1%
in tumors and 0–0.3% in normal tissues). However, approximately 3–70% of cells in the tissues surrounding the tumor were
BMDCs, and the percentage of BMDCs was highly associated with the inflammatory status of the tissue. In the present
study, no evidence was found to support the existence of fusion cells formed form BMDCs and tissue-specific stem cells.
Conclusions: In summary, our data suggest that although BMDCs may contribute to tumor progression, they are unlike to
contribute to tumor initiation.
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Introduction
A growing body of literature suggests that tumors originate from a
small portion of cells, referred to as cancer stem cells (CSCs) or
tumor initiating cells (TICs) because these cells bear stem cell-like
features such as self-renewal and differentiation [1]. To date, CSCs
have been demonstrated to exist in cancers of the hematopoietic
system [2], breast [3], brain [4], prostate [5], gastric [6], lung [7],
colon [8], and liver [9]. However, little is known regarding the
origin of CSCs. One possible origin of CSCs is the bone marrow, as
bone marrow derived cells (BMDCs) are frequently found in tumor
tissues and BMDCs have the ability to differentiate into many
different types of cells including mesenchymal cells, muscle cells and
epithelial cells, including hepatic cells. Recently, our knowledge of
the relationship between BMDCs and cancer progression has
dramatically improved. One interesting aspect is that cancer cells
actively recruit BMDCs to their ownmicroenvironment. BMDCs in
tumors are not only responsible for inflammation but also for tumor
angiogenesis [10]. CD45-positive BMDCs are frequently found in
tumor tissue, where they express vascular endothelial cell growth
factor receptor-1 (VEGFR-1) [11], a key receptor of VEGF. In
addition to inflammation, these CD45+/VEGFR1+ cells also
contribute to tumor angiogenesis. Thus, evidence demonstrates
that BMDCs provide a suitable microenvironment to facilitate
cancer metastasis [12].
However, it is unclear whether cancer cells originate from
BMDCs, and this hypothesis is frequently debated. One recent
report found that after chronic Helicobacter infection, BMDCs
accumulated in the gastric mucosa and eventually gave rise to
gastric cancer [6]. Furthermore, additional studies suggested that
oncogenic mutations of tissue stem cells or further differentiated
cells might create a pool of self-renewing cells in which those
mutations accumulated and finally resulted in cancer [4,5]. In bone
marrow transplantation models, it was demonstrated that BMDCs
were unlikely to be the origin of liver cancer [13] and skin cancer
[14]. To test whether cancer originates from BMDCs, the chemical
carcinogen n-nitrosodiethylamine (DEN) was used to induce tumor
development in mice following bone marrow transplantation. The
bone marrow of female recipient mice was eradicated by irradiation
and then reconstituted with bone marrow from normal male mice.
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The Y chromosome was used as marker to characterize the origin of
the induced tumor cells. Twenty tumors, including 12 liver tumors,
6 lung tumors, 1 bladder tumor and 1 nasopharyngeal tumor, were
successfully induced. Among these tumors, clonal expansion of Y-
positive (Y+) cells was not observed. The number of Y+ cells in the
tumors closely correlated with the number of infiltrating lympho-
cytes. We also found that most Y+ cells expressed both CD45 and
VEGFR-1. Our data suggested that, at least in our animal model,
BMDCs are not the origin of cancer stem cells, although they are
related to tumor inflammation and may contribute to the formation
of tumor neo-vessels.
Results
Detection of Mouse X- and Y-chromosomes by FISH
For the bone marrow transplantation (BMT), bone marrow cells
collected from 6 donor male mice were transplanted into 60
recipient female mice. As shown in Figure 1, FISH probes
hybridized to both metaphase and interphase chromosomes and
yielded strong and specific signals. FISH signals of the Y
chromosome were only detected in cells from donor male mouse
bone marrow (Figure 1B).
Bone Marrow Transplantation
All recipient mice survived the BMT. The overall level of
engraftment was 82.5–94.5% as assessed by calculating the
percentage of Y-positive cells among both peripheral lymphocytes
(Figure 1C) and bone marrow cells (Figure 1D). A total of 500 cells
was analyzed in each sample. This result indicates that the BMT
procedures were successful.
DEN-Induced Carcinogenesis
During the 30 weeks of chemically induced carcinogenesis, 34
BMT mice died. Complete autopsies were performed on each of
these mice, with the primary cause of death being extensive
pneumonia and hepatic failure. Tumors were induced in 20 of the
26 surviving mice; these tumors included 12 liver tumors, 6 lung
tumors, 1 bladder tumor and 1 nasopharyngeal tumor. Repre-
sentative images of the lung and liver tumors are shown in
Figure 2A and 2B, respectively. These tumors were resected,
embedded in paraffin, sectioned and histologically characterized
using H&E. Of the 6 induced lung cancers, 4 were characterized
as squamous cell carcinoma, and the remaining 2 were
characterized as adenocarcinoma (Figure 2C). All 12 liver tumors
were characterized as hepatocellular carcinoma (Figure 2D). Both
the bladder (Figure 2E) and nasopharyngeal cancers (Figure 2F)
were characterized as squamous cell carcinoma.
Distribution of BMDCs in DEN-Induced Tumors
To investigate whether DEN-induced cancers originated from
bone marrow, we used FISH to determine the percentage of Y-
positive (Y+) cells. In each case, 500–5,000 cells were counted to
calculate the percentage of Y+ cells in tumor specimens. In all DEN-
induced tumors, the frequency of Y+ cell was 0.2–0.6% in the liver
cancers (Figure 3B and 3C), 0–0.3% in the lung cancers (Figure 4),
0.6% in the bladder cancer (Figure 5) and 1% in the nasopharyngeal
cancer (Figure 6). Interestingly, the frequencies of Y+ cells were
extremely high in the tissues surrounding the tumor, where a large
percentage of infiltrating inflammatory cells and fibroblasts resided.
The frequency of Y+ cells in the tissue surrounding the tumor was
30–50% in the liver tumors (Figure 3B, 3C), 3–8% in the lung
tumors (Figure 4), 40% in the bladder tumor (Figure 5) and 70% in
the nasopharyngeal tumor (Figure 6). However, a significant
frequency of Y+ cells was not observed in the normal tissues
adjacent to the liver, lung and bladder tumors. These data suggest
that the cellular origin of the cancers is not the bone marrow.
To evaluate whether BMDCs can fuse with tumor cells, we
analyzed the number of X and Y signals in BMDCs in the tumors
Figure 1. Representative FISH results using X (green) and Y (red) probes. (A) A metaphase peripheral blood lymphocyte from a female
recipient mouse. (B) A metaphase peripheral blood lymphocyte from a male donor mouse. (C) Peripheral blood lymphocytes from a female recipient
mouse after BMT. A female lymphocyte is indicated by an arrow. (D) Bone marrow cells from a female recipient mouse after BMT. A female bone
marrow cell is indicated by an arrow. Magnification,6100 (A and B) or640 (C and D). Scale bars, 20 mm.
doi:10.1371/journal.pone.0030493.g001
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and their surrounding tissues. No fusion-derived karyotype
(XXY, XXXY) cells were found in our study. This result is
consistent with many other findings [6,11,15,16] and suggests
that cell fusion is not the main contribution of BMDCs to
malignant pathogenesis.
Discussion
Although the cancer stem cell hypothesis remains debated,
many scientists believe that cancers contain a small number of
cancer stem cells (CSCs). These CSCs are able to self-renew,
Figure 2. DEN-induced tumors in BMT mice. (A) Gross pathology of a representative lung cancer. (B) Gross pathology of a representative liver
cancer. Representative H&E staining sections for adenocarcinoma of the lung (C), hepatocellular carcinoma (D), squamous cell carcinoma of the
bladder (E), and nasopharyngeal cancer (F). Magnification,620 (C, D, E, and F). Scale bars, 50 mm.
doi:10.1371/journal.pone.0030493.g002
Figure 3. Comparison of the histopathological features and FISH data of adjacent serial sections of an HCC. (A) A representative H&E
staining image demonstrating the histopathological features of the HCC tissue and the surrounding tissue. (B) A representative FISH image of the
same area from an adjacent serial section constructed by the fusion of several images. (C) Magnification of areas from the tissue surrounding the
tumor (a) and the tumor tissue (b) in (B). T, tumor tissue. Magnification,620 (A & B). Scale bars, 20 mm.
doi:10.1371/journal.pone.0030493.g003
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differentiate, and resist chemotherapy and thus maintain the
cancer growth. To date, the origin of CSCs remains a mystery. At
least three possible origins of CSCs have been proposed, including
1) tissue-specific stem cells [17]; 2) BMDCs [6,15]; and 3) fusion
cells derived from BMDCs and tissue-specific progenitor or stem
cells [18–20]. In this study, we utilized a bone marrow
transplantation animal model to investigate the origin of CSCs
in chemically induced (DEN) tumors. DEN is a carcinogen that
can induce tumors in various organs including the liver and skin
and in the gastrointestinal, respiratory and hematopoietic systems
in mice. When metabolized, DEN in converted into an
electrophilic ethyldiazonium ion that can react with DNA bases
and form adducts and thus may cause DNA mutations and strand
breaks that ultimately contribute to pathogenesis [21]. In our
model, we used a high dose of DEN (60 ppm) in drinking water for
12 weeks to increase the frequency and shorten the period of
tumor formation. Using this strategy, tumors were successfully
induced in the liver, lung, bladder and nasopharynx.
BMDCs have the ability to differentiate into epithelial cells
during tissue repair in many organs, including the liver [22,23],
lungs, skin, eyes, GI tract and kidneys [24]. However, whether and
how BMDCs account for tissue repair is still debated. Although the
number of BMDCs was variable, most publications show that
BMDCs were recruited to tissue damage sites [25–28], whereas
other publication report that BMDCs were not detected in the
models used [29,30]. In murine liver and pancreatic tumor models,
the more advanced tumors had a higher tendency to recruit
BMDCs [31]. In our model, we found that the percentages of
BMDCs in both tumor and normal tissues were very low (,1%);
however, BMDCs were found in the tissue surrounding the tumor.
This area is infilitrated with inflammatory cells, suggesting that these
BMDCs were associated with inflammation. This result suggests
that BMDCs were less likely to be transformed into malignant cells
as none of the tumors in our model contained clustered Y+ cells.
Recent findings showed that BMDCs can incorporate into livers
and intestines through cell fusion [18–20], which raised the
possibility that BMDCs may play a role in regeneration and
tumorigenesis by fusing with progenitor or stem cells of the target
organ. However, many reports argue that there is no clear
evidence to demonstrate that cell fusion occurs between BMDCs
and target organ cells in their models [6,11,15,16]. In the present
study, we confirmed the lack of evidence to demonstrate cell fusion
both in tumors and in surrounding normal tissue by FISH.
Notably, although BMDCs were found incorporated into the
intestinal adenoma in APC-mutated multiple intestinal neoplasia
mice, none of adenomas ubiquitously consisted of BMDCs [20],
suggesting that the mechanism by which BMDCs contribute to
pathogenesis was not likely to be cell fusion. In summary, our data
showed that although BMDCs may contribute to tumor
progression, the possibility that BMDCs are the origin of the
tumor itself is extremely low.
Materials and Methods
Bone Marrow Transplantation (BMT)
Six- to eight-week old male and female C57BL/6J mice were
purchased from the Model Animal Research Center of Nanjing
University (Nanjing, China). The animal experiments were
performed in accordance with institutional guidelines, and the
study was approved by the ethics committee of Zhejiang
University (Approval ID: SYXK2004-0050). For the BMT, total
bone marrow was isolated from the femurs and tibias of donor
male mice, washed, triturated using a 20-gauge needle and passed
through a 40-mm nylon mesh cell strainer (Becton Dickson,
Franklin Lakes, NJ) to produce a single-cell suspension in PBS at a
density of 1.56107 cells/ml. The recipient female C57BL/6J mice
were irradiated with 900 rads from a 60Co irradiator, reconstituted
with 36106 donor marrow cells via tail vein injection or retro-
orbital sampling of anesthetized mice 36 hours later, and used for
experiments 4–5 weeks after recovery. To confirm successful
transplantation of donor bone marrow cells, recipient peripheral
blood and bone marrow cells were obtained 4 weeks after the
Figure 4. Comparison of the histopathological features and FISH data of adjacent serial sections of a squamous cell carcinoma in
the lung. (A) H&E staining image presenting the histopathological features of the lung cancer and the surrounding normal tissue. Magnification,
620. (B) H&E staining (upper) and FISH image (lower) of a magnified area in (A). T, tumor tissue; NT, non-tumor tissue. Magnification,640. Scale bars,
20 mm.
doi:10.1371/journal.pone.0030493.g004
BMDCs and Chemical Induced Tumor
PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e30493
BMT and examined for the presence of the Y-chromosome with
fluorescence in situ hybridization (FISH).
Chemically Induced Carcinogenesis with n-
Nitrosodiethylamine (DEN)
Approximately 4–5 weeks after BMT, 60 recipient mice were
fed DEN (60 ppm in drinking water, Sigma, St Louis, MO) for 12
weeks for two sessions with a 2-week separation interval to initiate
the process of carcinogenesis. The mice that survived were
sacrificed at 30 weeks.
Histological and Pathological Study
DEN-induced tumors were removed and fixed in 4% formalin
overnight. After dehydration, the tumor tissue was embedded in
paraffin. The tumor tissue in paraffin was serially sectioned (5 mm
in thickness), and select slides were routinely stained with
hematoxylin-eosin (H&E). All of the tumor sections were reviewed
in a blinded manner by two experienced pathologists.
Fluorescence in situ Hybridization
Two bacterial artificial chromosome (BAC) clones (RP24-
0090J19 and RP24-185C22) containing the sry gene of the mouse
Y chromosome were selected to identify cells derived from the
male mice. The BACs containing the DNA fragment from the
murine X7A.1 region (RP23-0170B5 and RP23-0011C16) were
used as control probes for the murine X chromosome. Paraffin-
embedded tissue sections adjacent to the H&E-stained sections
were selected for FISH detection. Sections were deparaffinized,
digested with protease K, and then hybridized with the
fluorophore-labeled BAC probes according to the method
described previously [32]. The FISH results were observed and
captured using a fluorescence microscope equipped with a cooled
Figure 5. Comparison of the histopathological features and FISH data of adjacent serial sections of a nasopharyngeal carcinoma
(NPC). (A) H&E staining image presenting the histopathological features of the NPC and the surrounding tissue. Magnification,620. (B & C) H&E
staining (upper) and FISH image (lower) of the magnified areas in (A). T, tumor tissue. Magnification,640. Scale bars, 20 mm.
doi:10.1371/journal.pone.0030493.g005
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CCD camera. The FISH signals were compared with the H&E
staining of the same area in a successive tumor section.
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